Tag: data

DUBAI, United Arab Emirates, June 21, 2026 (GLOBE NEWSWIRE) --

Pepeto announced today that its presale crossed $10.29 million as Bitcoin slipped to $63,650 and on-chain data shows the biggest wallets matching every BTC they bought across 2025 in just five months.

DUBAI, United Arab Emirates, June 20, 2026 (GLOBE NEWSWIRE) --

Pepeto moved into final preparation ahead of a major exchange listing, and the presale became the fastest closing raise of 2026 as rounds close inside days, because $10.29 million is raised, 170% APY staking runs live, three products are in production, and wallets are pouring in at a pace that tells the reader the sharpest capital has already locked the entry before the listing pulls the price out of reach forever.

DUBAI, United Arab Emirates, June 20, 2026 (GLOBE NEWSWIRE) --

Ethereum-based new crypto Pepeto confirms progress on the DeFi tools designed to reshape how the entire DeFi space works, and the signals building around this presale match the pattern that appeared before Dogecoin turned ordinary wallets, the kind that never imagined seven figures, into millionaires overnight. Experienced traders expect the same outcome from Pepeto.

마이애미, June 20, 2026 (GLOBE NEWSWIRE) --

, June 19, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs가 유럽 최초의 메모리 반도체 ETF인 Defiance Memory UCITS ETF(티커: DRAM)를 출시했다고 발표했다. 이 펀드는 메모리 반도체 및 데이터 저장 시스템의 개발, 제조, 상용화, 저장 기술과 관련된 기업들에 투자 기회를 제공하는 것을 목표로 한다.

New investor signal-intelligence platform reads social, forum, and news chatter across thousands of conversations — and surfaces the tickers the crowd is piling into, with the sentiment and catalysts behind them. Free to start.

Emily Sanford Fisher discusses how data centers, electrification, and infrastructure expansion are driving renewed electricity demand growth across the United States.

SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on June 18, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 140,860 shares of Iovance’s common stock to twenty-seven new, non-executive employees.

REGULATED INFORMATION
June 19, 2026, 10:30pm CET / 4:30pm ET